Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
An Unlikely Use for Diamonds
Tiny diamonds provide new possibilities for accurate measurements of processes inside living cells with potential to improve drug delivery and cancer therapeutics.
Microscopic “Walkers” Find Their Way Across Cell Surfaces
Technology could provide a way to deliver probes or drugs to cell structures without outside guidance.
Revalesio’s Drug Shows Promise in Treating Alzheimer’s
Multiple published research studies outline the potential for RNS60 to effectively treat Alzheimer’s disease by protecting neuronal function and restoring neuronal plasticity.
Getting Metabolism Right
Analysis of 89 models of metabolic processes finds flaws in 44 of them — but suggests corrections.
Persistent Pharmacokinetic Challenges to Pediatric Drug Development
Current knowledge of rational drug dose adjustments is limited, greater effort needs to be made to determine ontogenic factors that influence ADME.
‘Tissue Chip’ to Screen Neurological Toxins
UW-Madison team are developing a faster, more affordable way to screen for neural toxins.
Promise for Treatment of Pancreatic Cancer
Ultrasound microbubbles can improve tumor absorption of cancer drugs.
Animal Testing can Mislead Drug Discovery and Development
Several blockbuster drugs would not be on the market, if scientists had relied solely on drug-uptake in animal trials, according to new research.
Marijuana Compound May Offer Treatment for AD
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease.
New Advances in the Pre-clinical Evaluation of Hepatitis B Therapies
Imperial College London to present first public HBV Data from CN Bio in vitro liver model.
Scroll Up
Scroll Down
Return
Metabolomics as a Tool for Biomarker Discovery
Dr. Chris Beecher, Vice President of Biochemistry and Technology, Metabolon, Inc., speaking at Advances in Metabolic Profiling 2005
Date Posted: Friday, May 12, 2006
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Metabolomics Technology Applied to Non-Invasive Nash Biomarkers Research
Metabolon studied plasma profiles from subjects with nonalcoholic fatty liver disease.
Monday, May 17, 2010
Patents Awarded to Metabolon for Metabolomics Methods
The USPTO patents cover uses of metabolomics to identify diagnostic biomarkers for depression and schizophrenia.
Thursday, April 01, 2010
Metabolomics Aids in Understanding Mechanisms of Commonly Used Drugs
Metabolon announces publication of a new study which seeks to understand toxicological effects of Fenofibrate.
Thursday, August 13, 2009
Metabolon Announces First in a Series of new Research Tools
Metabolon releases mFocus TST™, a research use only assay for prostate cancer progression.
Wednesday, February 25, 2009
Metabolon Acquires Intellectual Property from Cogenics Icoria
Metabolon acquires the property portfolio including patents related to metabolomics methods and data analysis, carcinogenicity and toxicity biomarkers.
Wednesday, November 07, 2007
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv